![]() |
인쇄하기
취소
|
The belief of President Sung-gi Lim of Hanmi Pharm, which has focused on R&D investment for the past 15 years, has been glowing in the global pharmaceutical market.
On the 5th, Hanmi Pharm announced a license agreement for the Quantum Project, a portfolio of long-acting diabetes new drugs which have been developed by Hanmi Pharm.
For the agreement, Hanmi Pharm will receive an upfront payment ...